Transplantační medicína

Keep scrolling to explore ACS updates

Keep scrolling to explore ACS updates

Keep scrolling to explore ACS updates

Learn more about SoliSimplify study and SoliPersistence study 

Evolving strategies for type 2 diabetes management filmed at the Australian Diabetes Congress, 20 August 2025

Low platelet counts are one facet of ITP, but when we look at it from another angle, we see the multiple dimensions of ITP. ITP is a condition of complex immune dysregulation that reduces platelet counts—causing bleeding, bruising, fatigue, and other health-related quality-of-life (HRQoL) issues—while increasing inflammation and the risk of thromboembolic events (TEs).^1-5

Low platelet counts are one facet of ITP, but when we look at it from another angle, we see the multiple dimensions of ITP. ITP is a condition of complex immune dysregulation that reduces platelet counts—causing bleeding, bruising, fatigue, and other health-related quality-of-life (HRQoL) issues—while increasing inflammation and the risk of thromboembolic events (TEs).^1-5

Lavt blodplateantall er én side av ITP, men når vi ser det fra en annen vinkel, ser vi de mange dimensjonene ved ITP. ITP er en tilstand med kompleks immunologisk dysregulering som reduserer blodplateantallet – noe som forårsaker blødning, blåmerker, tretthet og andre helserelaterte livskvalitetsproblemer (HRQoL) – samtidig som det øker betennelse og risikoen for tromboemboliske hendelser (TE).^1-5

Patients reported significant quality of life (QoL) challenges related to their ITP¹

Patients reported significant quality of life (QoL) challenges related to their ITP¹

Pasienter rapporterte betydelige utfordringer i forhold til livskvalitet (QoL) relatert til deres sykdom¹

For ITP patients, several scales are available to measure and track fatigue and its impact on quality of life. These tools can help patients and healthcare providers gauge symptoms and adjust their ITP treatment accordingly.^1-4